LCI - Lannett to discontinue product lines expects impairment charge of $180M to $210M
Lannett (LCI) has decided to discontinue 23 lower gross margin product lines, which contributed ~$31M and ~$4M of net sales in FY 2020 and in Q1 2021, respectively.As a result of the discontinuance, the Company expects an estimated impairment charge in the range of $180M to $210M.
For further details see:
Lannett to discontinue product lines, expects impairment charge of $180M to $210M